Eyenovia Inc
NASDAQ:EYEN
Eyenovia Inc
Change in Working Capital
Eyenovia Inc
Change in Working Capital Peer Comparison
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Eyenovia Inc
NASDAQ:EYEN
|
Change in Working Capital
-$1.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Change in Working Capital
-$94m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Change in Working Capital
-$356m
|
CAGR 3-Years
21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pfizer Inc
NYSE:PFE
|
Change in Working Capital
-$5m
|
CAGR 3-Years
35%
|
CAGR 5-Years
69%
|
CAGR 10-Years
42%
|
|
Merck & Co Inc
NYSE:MRK
|
Change in Working Capital
-$2.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-24%
|
|
Eli Lilly and Co
NYSE:LLY
|
Change in Working Capital
-$5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-33%
|
See Also
What is Eyenovia Inc's Change in Working Capital?
Change in Working Capital
-1.5m
USD
Based on the financial report for Dec 31, 2023, Eyenovia Inc's Change in Working Capital amounts to -1.5m USD.
What is Eyenovia Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 1Y
35%
Over the last year, the Change in Working Capital growth was 35%.